Skip to content

Effects of Using Custom Photobiomodulation Therapy for the Treatment of Osteoarthritis of the Fingers and Rhizarthrosis

Effects of Using Custom Photobiomodulation Therapy for the Treatment of Osteoarthritis of the Fingers and Rhizarthrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05041231
Enrollment
46
Registered
2021-09-10
Start date
2021-08-25
Completion date
2023-01-20
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Osteoarthritis Both Hands, Osteoarthritis Finger, Osteoarthritis Hand

Brief summary

Osteoarthrosis (OA), a multifactorial degenerative process, is responsible for joint pain and functional limitation. In the hand, more specifically in the proximal and distal interphalangeal joints of the fingers, it is one of the sites of greatest manifestation of the disease. Numerous treatments, whether drug, rehabilitation or surgery, have been proposed with the aim of both interrupting the natural evolution of the disease and alleviating or stopping the symptoms. This study aims to evaluate the effectiveness of personalized Photobiomodulation Therapy (PBT) with regard to alleviating symptoms and improving the quality of life of these patients with the disease.

Interventions

DEVICEPhotobiomodulation therapy (PBT)

Any invasive procedures will be done. The treatment in question will be done by a device that looks like a bracelet, which is placed on the hand/fingers to emit light/laser and does not cause pain or temperature change. There will be 8 photobiomodulation sessions, 2 per week, 10 minutes each session. The dosimetric parameters of the therapy will be carried out in a standardized and personalized way, with programming of the light and all the necessary information so that the device can carry out the application of the treatment application of electromagnetic waves in the red and infrared spectral range 660-1000 nm).

DEVICESham Photobiomodulation therapy (Sham PBT)

Similar to active PBT, however, the device will not provide the active electromagnetic waves)

Sponsors

Tegos S.A.
CollaboratorUNKNOWN
Vita Care
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Clinical and radiological diagnosis of OA of the fingers of the hand and Rizarthrosis * Patients with pain for at least 3 months * Patients undergoing treatment and rehabilitation for finger OA and rhizarthrosis * Patient with good understanding of the Portuguese language who agrees to participate and sign the ICF

Exclusion criteria

* Posttraumatic arthritic changes * Systemic inflammatory arthritis (Rheumatoid Arthritis, Lupus Erythematosus, Psoriasis…) * Patients with local or systemic, acute or chronic infections

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline Pain at4 weeks and 2 monthsVisual analogue scale for pain
Change from Baseline Arm, Shoulder and Hand Disability4 weeks and 2 monthsThe Disabilities of the Arm, Shoulder and Hand Score

Secondary

MeasureTime frameDescription
Change from Baseline Hand grip4 weeks and 2 monthsHand grip strenght measured by Digital Hand Dynamometer
Change from Baseline Pinch force4 weeks and 2 monthsPulp to pulp (pinch) force
Willingness to recommend the treatment4 weeks and 2 monthsNet Promoter Score
Change from Baseline Hand Disability4 weeks and 2 monthsBrief Michigan questionnaire

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026